|
|||||
|
|
| Cost effectiveness of treatments for relapsed/refractory multiple myeloma: response to a methodology. RE: Hornberger J, Rickert J, Dhawan R, Liwing J, Aschan J, Löthgren M. The cost effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective. European Journal of Haematology 2010; 85 (6):484-491 | |
| 作者姓名： | Ishak J Rodrigues F |
| 摘 要： | |
| 本文献已被 PubMed 等数据库收录！ | |